FDMT Stock Earnings: 4D Molecular Therapeutics Beats EPS, Misses Revenue for Q1 2024
InvestorPlaceInvestorPlace – Stock Market News, Stock Advice & Trading Tips
FDMT stock results show that 4D Molecular Therapeutics beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
The post FDMT Stock Earnings: 4…